Fig. 5.
YES1 is a target of miR-129-2-3p. (A) The binding site between YES1 and miR-129-2-3p was analyzed by starBase. (B, C) The relationship between YES1 and miR-129-2-3p was confirmed by dual-luciferase reporter assay. (D, E) The expression of YES1 in tumor tissues (n=66) and normal tissues (n=66) was measured by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting. (F) The correlation between YES1 expression and miR-129-2-3p expression in tumor tissues was analyzed by Pearson correlation coefficient. (G, H) The expression of YES1 was measured by qRT-PCR and Western blot in cell lines. (I-K) The expression of YES1 in HGC-27/DR and AGS/DR cells transfected with miR-129-2-3p or anti-miR-129-2-3p at mRNA and protein levels was quantified by qRT-PCR and Western blotting.
YES1, YES proto-oncogene 1; UTR, untranslated region; WT, wild-type; MUT, mutant-type; NC, negative control; DR, doxorubicin; mRNA, messenger RNA. *p<0.05.